BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37249824)

  • 1. Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
    Bander ED; Kelly A; Ma X; Christos PJ; Wernicke AG; Stieg PE; Trichter S; Knisely JPS; Ramakrishna R; Schwartz TH
    J Neurooncol; 2023 Jun; 163(2):355-365. PubMed ID: 37249824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
    J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials.
    Palmisciano P; Haider AS; Balasubramanian K; D'Amico RS; Wernicke AG
    J Neurooncol; 2022 Aug; 159(1):117-133. PubMed ID: 35696019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    Julie DA; Lazow SP; Vanderbilt DB; Taube S; Yondorf MZ; Sabbas A; Pannullo S; Schwartz TH; Wernicke AG
    J Neurosurg; 2020 May; 134(5):1447-1454. PubMed ID: 32413856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
    Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
    Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Wernicke AG; Hirschfeld CB; Smith AW; Taube S; Yondorf MZ; Parashar B; Nedialkova L; Kulidzhanov F; Trichter S; Sabbas A; Ramakrishna R; Pannullo S; Schwartz TH
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1059-1068. PubMed ID: 28721889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.
    Koch MJ; Agarwalla PK; Royce TJ; Shih HA; Oh K; Niemierko A; Mauceri TC; Curry WT; Barker FG; Loeffler JS
    Neurosurgery; 2019 Nov; 85(5):E910-E916. PubMed ID: 31329941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
    Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
    Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.
    Wernicke AG; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Ramakrishna R; Pannullo SC; Stieg PE; Schwartz TH
    J Neurosurg; 2017 Apr; 126(4):1212-1219. PubMed ID: 27257835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
    Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
    Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachytherapy for central nervous system tumors.
    Bander ED; Knisely JPS; Schwartz TH
    J Neurooncol; 2022 Jul; 158(3):393-403. PubMed ID: 35546384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-Irradiation Using Brachytherapy for Recurrent Intracranial Tumors: A Systematic Review and Meta-Analysis of the Literature.
    Choi M; Zabramski JM
    Cureus; 2020 Aug; 12(8):e9666. PubMed ID: 32923261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
    Chen WC; Lafreniere M; Phuong C; Liu SJ; Baal JD; Lometti M; Morin O; Ziemer B; Vasudevan HN; Lucas CG; Hervey-Jumper SL; Theodosopoulos PV; Magill ST; Fogh S; Nakamura JL; Boreta L; Sneed PK; McDermott MW; Raleigh DR; Braunstein SE
    J Neurosurg; 2022 Jan; ():1-7. PubMed ID: 35061986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
    Imber BS; Young RJ; Beal K; Reiner AS; Giantini-Larsen AM; Krebs S; Yang JT; Aramburu-Nunez D; Cohen GN; Brennan C; Tabar V; Moss NS
    J Neurooncol; 2022 Sep; 159(3):609-618. PubMed ID: 35896906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.
    Wernicke AG; Lazow SP; Taube S; Yondorf MZ; Kovanlikaya I; Nori D; Christos P; Boockvar JA; Pannullo S; Stieg PE; Schwartz TH
    Oper Neurosurg (Hagerstown); 2016 Mar; 12(1):49-60. PubMed ID: 27774500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer.
    Parashar B; Port J; Arora S; Christos P; Trichter S; Nori D; Wernicke AG
    Brachytherapy; 2015; 14(5):648-54. PubMed ID: 25998071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
    Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
    J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
    Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
    J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.
    Wernicke AG; Yondorf MZ; Parashar B; Nori D; Clifford Chao KS; Boockvar JA; Pannullo S; Stieg P; Schwartz TH
    J Neurooncol; 2016 Mar; 127(1):145-53. PubMed ID: 26725100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.
    Gobitti C; Borsatti E; Arcicasa M; Roncadin M; Franchin G; Minatel E; Skrap M; Zanotti B; Tuniz F; Cimitan M; Capra E; Drigo A; Trovò MG
    Tumori; 2011; 97(5):614-9. PubMed ID: 22158493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.